These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

21 related articles for article (PubMed ID: 37472565)

  • 1. On the Improved Method of Treatment of Diseases of the Lungs, Throat, and Nasal Passages, by Inhalations of Atomized Fluids.
    Lyman WC
    Chic Med J; 1867 Sep; 24(9):420-429. PubMed ID: 37412858
    [No Abstract]   [Full Text] [Related]  

  • 2. Sulphurous-arsenical-ferruginous (thermal) water inhalations reduce nasal respiratory resistance and improve mucociliary clearance in patients with chronic sinonasal disease: preliminary outcomes.
    Staffieri A; Abramo A
    Acta Otolaryngol; 2007 Jun; 127(6):613-7. PubMed ID: 17503230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfurous-arsenical-ferruginous thermal water nasal inhalation and irrigation in children with recurrent upper respiratory tract infections: Clinical outcomes and predictive factors.
    Franz L; Manica P; Claudatus J; Frigo AC; Marioni G; Staffieri A
    Am J Otolaryngol; 2021; 42(6):103083. PubMed ID: 34049171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additional Cases, from a Paper on the "Use of Inhalations in the Treatment of Inflammations of the Nasal Passages and Their Appendages".
    Reilly FW
    Chic Med Exam; 1861 Nov; 2(11):613-616. PubMed ID: 37472565
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhalations with thermal waters in respiratory diseases.
    Zajac D
    J Ethnopharmacol; 2021 Dec; 281():114505. PubMed ID: 34371115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of computational fluid dynamics models for dosimetry of inhaled gases in the nasal passages.
    Kimbell JS; Subramaniam RP
    Inhal Toxicol; 2001 May; 13(5):325-34. PubMed ID: 11295865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxic and neoplastic responses in the nasal passages: future research needs.
    Bonnefoi M; Monticello TM; Morgan KT
    Exp Lung Res; 1991; 17(5):853-68. PubMed ID: 1959500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost-effectiveness of hypertonic saline inhalations for infant bronchiolitis: a decision analysis.
    Heikkilä P; Mecklin M; Korppi M
    World J Pediatr; 2018 Feb; 14(1):26-34. PubMed ID: 29476325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nasal obstruction].
    Vincent Y
    Rev Med Brux; 1997 Sep; 18(4):144-8. PubMed ID: 9411633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertonic saline inhalations in bronchiolitis-A cumulative meta-analysis.
    Heikkilä P; Renko M; Korppi M
    Pediatr Pulmonol; 2018 Feb; 53(2):233-242. PubMed ID: 29266869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial microbiota of the nasal passages across the span of human life.
    Bomar L; Brugger SD; Lemon KP
    Curr Opin Microbiol; 2018 Feb; 41():8-14. PubMed ID: 29156371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heated, humidified air for the common cold.
    Singh M
    Cochrane Database Syst Rev; 2004; (2):CD001728. PubMed ID: 15106160
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.